Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP221039.RACyOWK_tBZCnY4pjE0WiojxrwHmFHwyapjTD9tbYY7L4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP221039.RACyOWK_tBZCnY4pjE0WiojxrwHmFHwyapjTD9tbYY7L4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP221039.RACyOWK_tBZCnY4pjE0WiojxrwHmFHwyapjTD9tbYY7L4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP221039.RACyOWK_tBZCnY4pjE0WiojxrwHmFHwyapjTD9tbYY7L4130_provenance.
- NP221039.RACyOWK_tBZCnY4pjE0WiojxrwHmFHwyapjTD9tbYY7L4130_assertion description "[Furthermore, the majority of breast cancers (58%) showing decreased ING1 expression had metastasized to regional lymph nodes whereas only 9% of cancers with elevated ING1 expression, compared to adjacent normal tissues, were metastatic.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP221039.RACyOWK_tBZCnY4pjE0WiojxrwHmFHwyapjTD9tbYY7L4130_provenance.
- NP221039.RACyOWK_tBZCnY4pjE0WiojxrwHmFHwyapjTD9tbYY7L4130_assertion evidence source_evidence_literature NP221039.RACyOWK_tBZCnY4pjE0WiojxrwHmFHwyapjTD9tbYY7L4130_provenance.
- NP221039.RACyOWK_tBZCnY4pjE0WiojxrwHmFHwyapjTD9tbYY7L4130_assertion SIO_000772 10498868 NP221039.RACyOWK_tBZCnY4pjE0WiojxrwHmFHwyapjTD9tbYY7L4130_provenance.
- NP221039.RACyOWK_tBZCnY4pjE0WiojxrwHmFHwyapjTD9tbYY7L4130_assertion wasDerivedFrom befree-20140225 NP221039.RACyOWK_tBZCnY4pjE0WiojxrwHmFHwyapjTD9tbYY7L4130_provenance.
- NP221039.RACyOWK_tBZCnY4pjE0WiojxrwHmFHwyapjTD9tbYY7L4130_assertion wasGeneratedBy ECO_0000203 NP221039.RACyOWK_tBZCnY4pjE0WiojxrwHmFHwyapjTD9tbYY7L4130_provenance.
- befree-20140225 importedOn "2014-02-25" NP221039.RACyOWK_tBZCnY4pjE0WiojxrwHmFHwyapjTD9tbYY7L4130_provenance.